ClinicalTrials.Veeva

Menu
S

Sanatorio Parque | Sede Consultorios Sanatorio Parque - Servicio de Neumonologia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Enzalutamide
Sacituzumab
Platinum
Belzutifan
Sotatercept
Ralinepag
Milvexian
Abiraterone Acetate
Lenvatinib

Parent organization

This site is a part of Sanatorio Parque

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

35 of 67 total trials
Locations recently updated

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) (LITESPARK-033)

Researchers are looking for more ways to treat advanced renal cell carcinoma (RCC) that is recurrent. Researchers want to learn if recurrent advanced...

Enrolling
Renal Cell Carcinoma
Drug: Belzutifan
Drug: Zanzalintinib

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine cal...

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: Prednisone
Drug: Ifinatamab deruxtecan
Recently updated

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that...

Enrolling
Urinary Bladder Neoplasms
Carcinoma in Situ
Biological: Intismeran autogene
Biological: BCG

Researchers are looking for new ways to treat types of breast cancer that are both:* High-risk, which means the cancer may have a higher chance of ge...

Enrolling
Triple Negative Breast Neoplasms
Breast Neoplasms
Drug: Carboplatin
Drug: Cyclophosphamide

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Ph...

Invitation-only
Hypertension
Familial Primary Pulmonary Hypertension
Drug: Ralinepag

This study will compare the efficacy and safety of belzutifan + lenvatinib versus cabozantinib in participants with advanced renal cell carcinoma (RC...

Active, not recruiting
Carcinoma, Renal Cell
Drug: Lenvatinib
Drug: Belzutifan

This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or...

Enrolling
Non-small Cell Lung Cancer
Other: Placebo
Drug: Calderasib
Locations recently updated

The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin n...

Enrolling
Non-small Cell Lung Cancer
Other: Placebo
Biological: Intismeran autogene

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Active, not recruiting
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in partici...

Enrolling
CLL
Small-Cell Lymphoma
Drug: Nemtabrutinib
Biological: Rituximab

The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP...

Active, not recruiting
Castration-Resistant Prostatic Cancer
Drug: Prednisone
Drug: New Formulation of Niraparib and Abiraterone Acetate (AA)

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer that has spread through t...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: sigvotatug vedotin
Drug: docetaxel

This study is to assess the pharmacokinetics (PK) and safety of SC pembrolizumab formulated with berahyaluronidase alfa (MK-3475A) versus (vs) intrav...

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Drug: Pegylated filgrastim
Drug: Cisplatin
Locations recently updated

Researchers want to know if V940 (the study treatment) given with pembrolizumab and chemotherapy can treat metastatic treatment-naive squamous non-sm...

Enrolling
Squamous Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Biological: V940

This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achievi...

Enrolling
Non Small Cell Lung Cancer
Biological: Sacituzumab tirumotecan
Drug: Carboplatin

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy...

Enrolling
Non-small Cell Lung Cancer
Drug: Relatlimab
Drug: Nivolumab
Locations recently updated

Researchers are looking for new ways to treat people with extensive-stage small cell lung cancer (SCLC) that has relapsed or is refractory. Gocatamig...

Enrolling
Small Cell Lung Cancer
Biological: Gocatamig
Biological: Durvalumab

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Enrolling
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Ziltivekimab
Drug: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Janssen (J&J Innovative Medicine) logo
Boehringer Ingelheim logo
Acceleron Pharma logo
Bristol-Myers Squibb (BMS) logo
Daiichi Sankyo logo
H
Pfizer logo
United Therapeutics logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems